Recall of Medline Anterior Hip Pack Due to Safety Issue
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Medline Industries is recalling 14,379 Anterior Hip Packs because they contain recalled components that could lead to health risks for patients.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 16, 2026 and geographically references United States. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Devices.
Recall of Medline Anterior Hip Pack
What Happened
Medline Industries, LP is recalling the Anterior Hip Pack due to kits containing recalled Olympus biopsy valves. These valves have been associated with complaints of rubber fragment detachment, which could result in a foreign body in a patient's tracheobronchial tree, potentially requiring intervention, along with risks of inflammatory response, hypoxia, and prolonged procedures.
Which Products Are Affected
The affected product is MEDLINE ANTERIOR HIP PACK DYNJ64672B. A total of 14,379 kits are involved. The product has codes: UDI-DI 10195327377496 (EA), 40195327377497 (CS), and LOT 23LMD300. Distribution occurred nationwide in the United States, specifically in the states of CA, FL, IL, IN, KY, MA, MD, MT, NY, OH, PA, TN, and TX.
What You Should Do
Consumers should contact the recalling firm, Medline Industries, LP, at their address: 3 Lakes Dr, Northfield, IL 60093-2753, for information on returns or refunds. Refer to the FDA for the official recall notice.
Why This Matters
This recall highlights potential safety risks in medical devices that could affect patient health, emphasizing the need for immediate action to prevent complications from defective components.
Source
Attributed to FDA, recall number Z-1711-2026.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,308 characters here).
Similar severity timing
Same severity (high) notices issued closest in time to April 16, 2026.
Frequently Asked Questions
Common questions about this FDA recall.